News from Exosome Diagnostics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

04 Aug, 2014, 08:00 ET Exosome Diagnostics Announces Appointment of Thomas McLain as Chief Executive Officer

 Exosome Diagnostics, a leading developer of non-invasive, biofluid-based molecular diagnostics, today announced the appointment of Thomas...


03 Jun, 2014, 08:00 ET Exosome Diagnostics Announces Appointment of Vincent J. O'Neill, M.D. As Chief Medical Officer

Exosome Diagnostics, a leading developer of non-invasive, biofluid-based molecular diagnostics, today announced that Vincent J. O'Neill, M.D., has...


28 May, 2014, 08:00 ET Exosome Diagnostics Announces Appointment of William J. Kelly As Chief Financial Officer

 Exosome Diagnostics, a leading developer of non-invasive, biofluid-based molecular diagnostics, today announced that William J. Kelly has been...


13 Jan, 2014, 02:00 ET Exosome Diagnostics and QIAGEN Expand Collaboration to Develop Non-Invasive Biofluid Diagnostic for Lung Cancer

 Exosome Diagnostics today announced an expansion of its strategic collaboration with QIAGEN to develop non-invasive molecular diagnostics for...


30 Sep, 2013, 08:00 ET Cedars-Sinai Medical Center to Use Exosome Diagnostics Exosome RNA Biofluid Kits in Neo-Natal Setting and Cancer for Development of Personalized Medicine Diagnostics

 Exosome Diagnostics today announced that it has selected Cedars-Sinai Medical Center to participate in an early technology access program for...


19 Sep, 2013, 08:00 ET Exosome Diagnostics Enters Collaboration Agreement with Lilly for Exosome Blood-Based Biomarker Discovery

 Exosome Diagnostics today announced it has entered into a collaboration agreement with Eli Lilly and Company (NYSE: LLY) for biomarker...


21 Aug, 2013, 08:00 ET Mount Sinai and Exosome Diagnostics Partner to Accelerate Translation of Body Fluid Molecular Diagnostics to Overcome Limitations of Tissue Biopsy in Areas of Critical Unmet Medical Needs

 The Icahn School of Medicine at Mount Sinai and Exosome Diagnostics today announced a collaboration on the research...


23 Jul, 2013, 16:00 ET Exosome Diagnostics and QIAGEN Partner to Launch Comprehensive Line of Biofluid Nucleic Acid Kits to Address Limitations of Tissue Biopsy in Clinical Research Market

 Exosome Diagnostics and QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced a partnership to develop and commercialize...


08 Jul, 2013, 08:00 ET Exosome Diagnostics Names Joseph Slattery to the Board of Directors

 Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic tests for use in personalized medicine, today announced that...


08 May, 2013, 11:00 ET Exosome Diagnostics Presents Data Demonstrating Utility of Urine Exosome Technology to Predict Prostate Biopsy Outcome at American Urological Association Annual Meeting

 Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic products for use in personalized medicine research and...


29 Apr, 2013, 08:00 ET Exosome Diagnostics Names Kapil Dhingra Chairman of the Board of Directors

Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic tests for use in personalized medicine, today announced that Kapil...


16 Apr, 2013, 08:00 ET Exosome Diagnostics Presents Data Demonstrating Clinical Applications of Exosome Technology in Brain Cancer, Prostate Cancer, and Alzheimer's Disease at the International Society for Extracellular Vesicles 2013 Annual Meeting

Exosome Diagnostics, a developer of biofluid-based molecular diagnostic products for use in personalized medicine, today announced data...


08 Apr, 2013, 13:00 ET Exosome Presents Late-Breaking Study Demonstrating Ability to Profile RNA from Archived Clinical Trial Blood Samples at 2013 American Association of Cancer Research Annual Meeting

 Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostics for use in personalized medicine, today announced that the...


26 Oct, 2012, 08:00 ET Exosome Diagnostics Selects Promega Corp. for cGMP Clinical Sample Concentrator Kit

Exosome Diagnostics today announced it has reached an agreement with Promega Corporation to be the exclusive supplier of its Urine Clinical Sample...


04 Jun, 2012, 08:00 ET Exosome Diagnostics Signs Agreement with Life Technologies to Use Real-Time PCR Platform for Exosome Biofluid In Vitro Oncology Diagnostics

Exosome Diagnostics today announced it has reached agreement with Life Technologies to use the Applied Biosystems® (ABI) 7500 Fast Dx...


23 May, 2012, 10:30 ET Exosome Diagnostics Presents Data at American Urology Association Demonstrating Potential Utility of Urine Exosomes to Non-invasively Detect and Manage Prostate Cancer

Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic tests for use in personalized and non-invasive cancer diagnostics,...


28 Mar, 2012, 08:30 ET Kapil Dhingra, Former Head of Roche Oncology, Joins Exosome Diagnostics Board of Directors

Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic tests for use in personalized and non-invasive cancer diagnostics,...


01 Feb, 2012, 08:00 ET EUR 1.0 Million Grant Awarded to Exosome Diagnostics and Ludwig Maximilian University from German Federal Ministry for Education and Research to Develop Biofluid-Derived Exosome Diagnostics

 Exosome Diagnostics GmbH, a subsidiary of Exosome Diagnostics, Inc., and the Department of Dermatology at the Ludwig Maximilian...


13 Oct, 2011, 08:00 ET The Prostate Cancer Foundation and Exosome Diagnostics Collaborate to Accelerate Clinical Validation of Exosome Biofluid Molecular Diagnostics in Prostate Cancer

The Prostate Cancer Foundation (PCF) and Exosome Diagnostics today are announcing a multi-year collaboration to accelerate clinical validation of...


04 Oct, 2011, 07:00 ET Exosome Diagnostics Announces Additions to Management and Scientific Advisory Board as Company Expands Clinical Validation Studies in Oncology

Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic tests for use in personalized medicine, today announced the...


17 Nov, 2008, 13:48 ET Blood Exosomes Shown to Contain Tumor-Specific Genetic Information for Brain Cancer

Exosome Diagnostics Developing Blood Test to Help Monitor Status and Eligibility of Brain Tumors to Drug Treatments Tiny vesicles called...